Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert T Foster Insider Profile
4 Followers
Robert T Foster, CEO and Director, Director at Hepion Pharmaceuticals, holds 50.47K shares in Hepion Pharmaceuticals (Ticker: HEPA), holds ― shares in Aurinia Pharmaceuticals (Ticker: AUPH). Most recently, Robert T Foster Bought ― shares of Hepion Pharmaceuticals on Sep 19, 2023 for an estimated value of 8.96K.
Robert T Foster Hepion Pharmaceuticals (HEPA)CEO and Director, Director
Hepion Pharmaceuticals (HEPA)
CEO and Director, Director
Ranked #91,819 out of 98,624 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-68.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert T Foster holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 18, 2021 - Feb 18, 2022
Return:-53.10%
The most profitable trade made by Robert T Foster
Robert T Foster's Trading History
Hepion Pharmaceuticals
Sep 19, 2023
CEO and Director, Director
Informative Buy
8.96K
$68.64K
Aurinia Pharmaceuticals
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Robert T Foster's performance on stock
You May Also Like
Robert T Foster insider profile FAQ
What is the percentage of profitable transactions made by Robert T Foster?
The percentage of profitable transactions made by Robert T Foster is 0%.
What is the average return per transaction made by Robert T Foster?
The average return per transaction made by Robert T Foster is -68.30%.
What stocks does Robert T Foster hold?
Robert T Foster holds: HEPA, AUPH stocks.
What was Robert T Foster’s latest transaction?
Robert T Foster latest transaction was an Informative Buy of $8.96K.
What was Robert T Foster's most profitable transaction?
Robert T Foster’s most profitable transaction was an Informative Buy of HEPA stock on February 18, 2021. The return on the trade was -53.10%.
What is Robert T Foster's role in Hepion Pharmaceuticals?
Robert T Foster's role in Hepion Pharmaceuticals is CEO and Director, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.